| Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies IA Abela, L Berlinger, M Schanz, L Reynell, HF Günthard, P Rusert, ... PLoS pathogens 8 (4), e1002634, 2012 | 242 | 2012 |
| MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1 CR Ruprecht, A Krarup, L Reynell, AM Mann, OF Brandenberg, ... Journal of Experimental Medicine 208 (3), 439-454, 2011 | 128 | 2011 |
| Large and small cerebral vessel involvement in severe COVID-19: detailed clinical workup of a case series E Keller, G Brandi, S Winklhofer, LL Imbach, D Kirschenbaum, K Frontzek, ... Stroke 51 (12), 3719-3722, 2020 | 100 | 2020 |
| Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools A Ulyte, T Radtke, IA Abela, SR Haile, C Berger, M Huber, M Schanz, ... bmj 372, 2021 | 86 | 2021 |
| SARS-CoV-2 variants reveal features critical for replication in primary human cells MO Pohl, I Busnadiego, V Kufner, I Glas, U Karakus, S Schmutz, M Zaheri, ... PLoS biology 19 (3), e3001006, 2021 | 56 | 2021 |
| Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity IA Abela, C Pasin, M Schwarzmüller, S Epp, ME Sickmann, MM Schanz, ... Nature Communications 12 (1), 6703, 2021 | 42 | 2021 |
| Antibody response to SARS-CoV-2 vaccination in patients following allogeneic hematopoietic cell transplantation A Huang, C Cicin-Sain, C Pasin, S Epp, A Audigé, NJ Müller, J Nilsson, ... Transplantation and cellular therapy 28 (4), 214. e1-214. e11, 2022 | 37 | 2022 |
| Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study A Ulyte, T Radtke, IA Abela, SR Haile, J Braun, R Jung, C Berger, A Trkola, ... International journal of public health 65, 1549-1557, 2020 | 36 | 2020 |
| Antibody response in immunocompromised patients after the administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine BNT162b2 or mRNA-1273: a … B Speich, F Chammartin, IA Abela, P Amico, MP Stoeckle, ... Clinical infectious diseases 75 (1), e585-e593, 2022 | 34 | 2022 |
| Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland A Ulyte, T Radtke, IA Abela, SR Haile, J Blankenberger, R Jung, C Capelli, ... BMJ open 11 (7), e047483, 2021 | 34 | 2021 |
| Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents DM Byonanebye, MN Polizzotto, M Law, K Petoumenos, N Rose, ... Aids 35 (Supplement 2), 869-882, 2021 | 33 | 2021 |
| Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease I Busnadiego, IA Abela, PM Frey, DA Hofmaenner, TC Scheier, ... PLoS biology 20 (7), e3001709, 2022 | 31 | 2022 |
| Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report J Werner, I Reichen, M Huber, IA Abela, M Weller, I Jelcic BMC Infectious Diseases 21, 1-7, 2021 | 28 | 2021 |
| Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response M Marconato, IA Abela, A Hauser, M Schwarzmüller, R Katzensteiner, ... The Journal of Clinical Investigation 132 (12), 2022 | 26 | 2022 |
| Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona A Ulyte, T Radtke, IA Abela, SR Haile, P Ammann, C Berger, A Trkola, ... Swiss medical weekly 151, w30092, 2021 | 23 | 2021 |
| Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office D Weissberg, J Böni, SK Rampini, V Kufner, M Zaheri, PW Schreiber, ... Antimicrobial Resistance & Infection Control 9, 1-8, 2020 | 22 | 2020 |
| Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV Cohort Study: a systematic re-screening for hepatitis C RNA two years following a … K Kusejko, L Salazar-Vizcaya, C Shah, M Stöckle, C Béguelin, P Schmid, ... Clinical Infectious Diseases 75 (10), 1723-1731, 2022 | 18 | 2022 |
| Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV F Chammartin, K Kusejko, C Pasin, A Trkola, M Briel, P Amico, ... Aids 36 (10), 1465-1468, 2022 | 16 | 2022 |
| Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients IA Abela, AU Scherrer, J Böni, S Yerly, T Klimkait, M Perreau, HH Hirsch, ... Clinical infectious diseases 70 (2), 297-303, 2020 | 13 | 2020 |
| A cluster of scedosporiosis in lung transplant candidates and recipients: the Zurich experience and review of the literature IA Abela, C Murer, MM Schuurmans, JW Schmitt, F Muller, F Imkamp, ... Transplant Infectious Disease 20 (1), e12792, 2018 | 13 | 2018 |
Huldrych F. GünthardProfessor for Infectious Diseases, University Hospital ZurichVerified email at usz.ch
